[go: up one dir, main page]

HK1141945A1 - Methods of treating non-alcoholic steatohepatitis (nash) using cysteamine products - Google Patents

Methods of treating non-alcoholic steatohepatitis (nash) using cysteamine products Download PDF

Info

Publication number
HK1141945A1
HK1141945A1 HK10108405.0A HK10108405A HK1141945A1 HK 1141945 A1 HK1141945 A1 HK 1141945A1 HK 10108405 A HK10108405 A HK 10108405A HK 1141945 A1 HK1141945 A1 HK 1141945A1
Authority
HK
Hong Kong
Prior art keywords
cysteamine
levels
nash
hfd
treatment
Prior art date
Application number
HK10108405.0A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1141945B (en
Inventor
Ranjan Dohil
Jerry Schneider
Original Assignee
The Regents Of The University Of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40679016&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1141945(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by The Regents Of The University Of California filed Critical The Regents Of The University Of California
Publication of HK1141945A1 publication Critical patent/HK1141945A1/en
Publication of HK1141945B publication Critical patent/HK1141945B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HK10108405.0A 2007-11-30 2008-11-28 Methods of treating non-alcoholic steatohepatitis (nash) using cysteamine products HK1141945B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US99151707P 2007-11-30 2007-11-30
US60/991,517 2007-11-30
US8539708P 2008-07-31 2008-07-31
US61/085,397 2008-07-31
PCT/US2008/085064 WO2009070781A1 (en) 2007-11-30 2008-11-28 Methods of treating non-alcoholic steatohepatitis (nash) using cysteamine products

Publications (2)

Publication Number Publication Date
HK1141945A1 true HK1141945A1 (en) 2010-11-26
HK1141945B HK1141945B (en) 2013-08-09

Family

ID=

Also Published As

Publication number Publication date
SG10201403200RA (en) 2014-10-30
US8263662B2 (en) 2012-09-11
ZA201003670B (en) 2011-08-31
RU2498795C2 (ru) 2013-11-20
JP2014237670A (ja) 2014-12-18
ES2417179T3 (es) 2013-08-06
AR069500A1 (es) 2010-01-27
US20120015005A1 (en) 2012-01-19
JP6121951B2 (ja) 2017-04-26
BRPI0819690A2 (pt) 2014-10-07
US7994226B2 (en) 2011-08-09
CA2706768C (en) 2016-06-28
EP2636404B1 (en) 2019-03-20
MX360827B (es) 2018-11-16
MY156316A (en) 2016-02-11
EP2636404A3 (en) 2013-10-16
US20100303870A1 (en) 2010-12-02
CY1114126T1 (el) 2016-07-27
TWI535435B (zh) 2016-06-01
CL2008003582A1 (es) 2009-04-03
TW201513855A (zh) 2015-04-16
US10307386B2 (en) 2019-06-04
DK2214480T3 (da) 2013-07-08
TWI478710B (zh) 2015-04-01
CN104825430A (zh) 2015-08-12
CN104825430B (zh) 2018-05-04
AU2008329628A1 (en) 2009-06-04
HRP20130590T1 (xx) 2013-08-31
KR20100091219A (ko) 2010-08-18
JP2017165735A (ja) 2017-09-21
AU2008329628B2 (en) 2014-06-26
IL205909B (en) 2018-05-31
NZ585732A (en) 2012-02-24
US9149448B2 (en) 2015-10-06
US9511038B2 (en) 2016-12-06
BRPI0819690B1 (pt) 2019-07-30
CA2706768A1 (en) 2009-06-04
CN101932238A (zh) 2010-12-29
IL254586A0 (en) 2017-11-30
JP2011505375A (ja) 2011-02-24
WO2009070781A1 (en) 2009-06-04
JP5583022B2 (ja) 2014-09-03
BRPI0819690B8 (pt) 2021-05-25
EP2214480A4 (en) 2010-09-29
US20170304233A1 (en) 2017-10-26
PT2214480E (pt) 2013-07-23
EP2636404A2 (en) 2013-09-11
TW200927093A (en) 2009-07-01
US20160143865A1 (en) 2016-05-26
EP2214480B1 (en) 2013-03-27
US20130183351A1 (en) 2013-07-18
EP2214480A1 (en) 2010-08-11
PL2214480T3 (pl) 2013-11-29
MX2010005921A (es) 2010-06-11
RU2010126631A (ru) 2012-01-10
CN101932238B (zh) 2015-04-08
IL205909A0 (en) 2010-11-30

Similar Documents

Publication Publication Date Title
US10307386B2 (en) Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products
EP1919458A2 (en) Enterically coated cysteamine, cystamine and derivatives thereof
US10537528B2 (en) Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine compounds
US20200163897A1 (en) Methods of treating liver diseases associated with portal tract or periportal inflammation
AU2014233607B2 (en) Methods of Treating Non-Alcoholic Steatohepatitis (NASH) Using Cysteamine Products
HK1141945B (en) Methods of treating non-alcoholic steatohepatitis (nash) using cysteamine products
HK1189802B (en) Methods of treating non-alcoholic steatohepatitis (nash) using cysteamine products
HK1189802A (en) Methods of treating non-alcoholic steatohepatitis (nash) using cysteamine products
AU2017254872A1 (en) Enterically coated cysteamine, cystamine and derivatives thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20201124